
Mathias Jucker
Mathias Jucker is a neurobiologist and researcher at the German Center for Neurodegenerative Diseases in Tübingen, specializing in Alzheimer’s disease. He has been actively involved in the exploration of antibody treatments and their potential for preventing dementia. Jucker is optimistic about the future of Alzheimer's research, particularly regarding the identification of toxic protein aggregates that contribute to nerve cell death, and he advocates for early screening and intervention.
Not in the pool (under ¢1).
Recent news mentions
Mathias Jucker has been waiting for a breakthrough in Alzheimer's research for half of his research life.
Trump greift die NIH anMathias Jucker from the German Center for Neurodegenerative Diseases in Tübingen explains the potential risks and benefits of new antibody treatments for Alzheimer's patients.
Antikörper bremsen Alzheimer – können sie künftig die Demenz verhindern?



